The complex interaction
of cells with biomaterials (i.e., materiobiology)
plays an increasingly pivotal role in the development of novel implants,
biomedical devices, and tissue engineering scaffolds to treat diseases,
aid in the restoration of bodily functions, construct healthy tissues,
or regenerate diseased ones. However, the conventional approaches
are incapable of screening the huge amount of potential material parameter
combinations to identify the optimal cell responses and involve a
combination of serendipity and many series of trial-and-error experiments.
For advanced tissue engineering and regenerative medicine, highly
efficient and complex bioanalysis platforms are expected to explore
the complex interaction of cells with biomaterials using combinatorial
approaches that offer desired complex microenvironments during healing,
development, and homeostasis. In this review, we first introduce materiobiology
and its high-throughput screening (HTS). Then we present an in-depth
of the recent progress of 2D/3D HTS platforms (i.e., gradient and
microarray) in the principle, preparation, screening for materiobiology,
and combination with other advanced technologies. The Compendium for
Biomaterial Transcriptomics and high content imaging, computational
simulations, and their translation toward commercial and clinical
uses are highlighted. In the final section, current challenges and
future perspectives are discussed. High-throughput experimentation
within the field of materiobiology enables the elucidation of the
relationships between biomaterial properties and biological behavior
and thereby serves as a potential tool for accelerating the development
of high-performance biomaterials.